Compared to the deals we’ve been used to from Life Technologies (formerly known as Invitrogen) their $20 million purchase of a Houston, Texas based VisiGen Biotechnologies isn’t all that impressive. But it could be huge for Life and for the business of DNA sequencing.
Primary founder Susan Hardin remains at the helm as president and CEO, while the other five co-founders have chosen to stay at the university. . . . VisiGen has been developing a brainchild of Hardin — a radically new method of sequencing DNA that could achieve the goal of sequencing a human genome in one day at a cost of $1,000. A genome is the genetic code in a person’s DNA.
According to a story in the Houston Business Journal the cost of sequencing the first DNA was $3 billion. So doing it for $1,000 would make it a little more widely accessible.
[Link: Houston Business Journal]
RSS Feed-Posts